JULIE TUCKER: Open Payments
NPI 1467824284 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,378 in 64 payments from 21 companies in 2025. Trend: 2023 $1,645 · 2024 $541 · 2025 $1,378
Food & beverage: $1,335Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $290 |
| Insulet Corporation | 11 | $164 |
| Mannkind Corporation | 4 | $101 |
| Dexcom, Inc. | 4 | $100 |
| Tandem Diabetes Care, Inc. | 3 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| Corcept Therapeutics | 3 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Abbott Laboratories | 2 | $44 |
| Madrigal Pharmaceuticals | 2 | $44 |
Products named: Omnipod, Wegovy, AFREZZA, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, JARDIANCE, Korlym, CRENESSITY.
Industry payments across MI — which companies pay providers there.
